Goldenberg’s Inflation Reduction Act Hits Big Pharma Hard

TL/DR –

The Inflation Reduction Act, signed into law by President Biden, is expected to impact big pharmaceutical companies significantly. The law institutes a rebate program between drug manufacturers and insurance groups, where manufacturers must rebate any price increases above the inflation rate back to insurance groups. This law aims to reduce the financial pressure on American consumers resulting from high drug prices.

Fred L. Goldenberg: Inflation Reduction Act Challenges Big Pharma

The Inflation Reduction Act is taking on big pharma, as reported by Fred L. Goldenberg. The act aims to reduce the financial burden of expensive medications for consumers. This is accomplished through a series of measures designed to decrease the inflated prices of drugs, thereby making them more accessible to the public. It’s an attempt to address common questions like, “Why are medications so expensive?” and “What is being done to make healthcare more affordable?”

—
Read More US Economic News